Search results for #CellTherapies
Join us Friday for our #BridgingtheGap #webinar as we run diagnostics of patient access to advanced therapies together with Dr. Miguel Forte, ISCT President-Elect. Register now: hubs.ly/Q02vy4Mn0 @EWhiteheadFdn #CellandGene #CellTherapies #ClinicalTrials
A brief history of #ADCs, exploring what they can teach us about advancing #cancer treatments, and offering insights into challenges and opportunities that lie ahead for ADCs and #celltherapies. pharmaphorum.com/rd/emergence-a…
Speaking with @Xtalks, Dominic Borie, MD, PhD, President of R&D shares insights about how we’re shaping the landscape of #celltherapies for #autoimmunedisease. clinicaledge.xtalks.com/magazine/issue…
Regulatory considerations and validation strategies for #mycoplasmatesting for #celltherapies Regulatory expectations for #mycoplasma testing and a review of a sample validation study design and analysis are discussed Read the #article or #poster: buff.ly/448DH0S
#Celltherapies require specialized processes to remain viable and functional throughout manufacturing, storage, and transport. This #infographic gives an overview of a method to optimize #cryopreservation processes for cell therapies View below: buff.ly/3QibkYf
A brief history of #ADCs, exploring what they can teach us about advancing #cancer treatments, and offering insights into challenges and opportunities that lie ahead for ADCs and #celltherapies. pharmaphorum.com/rd/emergence-a…
Parse Biosciences announced it has launched its Laboratory Automation Provider Program, enabling automation providers to readily support the adoption of Parse’s Evercode™ single cell products. tinyurl.com/4vdwu2aw #automation #celltechnologies #CellTherapies #hamilton #WBO
Join us at ISCT 2024 as we address critical challenges in key areas such as #raredisease, unapproved #celltherapies and #patientaccess, and deep dive into novel technologies such as #CART, #iPSC and #EVs. Register your interest to claim your #mediapass: buff.ly/4ddujxc
From the Strengthening Pathways for Cell and Gene Therapies report, we see that the majority of #celltherapies and cell-based immunotherapies are autologous. Learn about the manufacturing and delivery of cell and #genetherapies here: bit.ly/4aKJE6L #PharmaDeals
#Immunotherapy & #celltherapies have emerged as important areas of #research that greatly influence the production of cancer therapeutics, personalized medicine, and new drug delivery mechanisms. Make your mark! Share your research - bit.ly/4ascxV4 #celltherapies2024
The #ASGCT24 annual meeting, May 7-11 in Baltimore, is just around the corner. #BioSpace looks at five #CellandGeneTherapy #regulatory decisions to watch in 2024. biospace.com/article/5-cell… #FDA #ASGCT2024 #celltherapy #genetherapy #cartcelltherapy #celltherapies #genetherapies
#LSINW24 Company/research institution presentations continue with presentations on Kidney, Pancreas, and #Pharma, #CellTherapies, and #Entrepreneurial Forum part 1.
Arsenal Biosciences will present 4 posters at the upcoming #ASGCT2024 in Baltimore May 7-10, highlighting our portfolio of #celltherapies in development including #AB1015 and #AB2100, which are being studied as potential treatments for #ovariancancer and #kidneycancer,…
Fantastic news for new #celltherapies being developed for #Myeloma #mmsm patients. This will allow for accelerated approval using MRD as an early endpoint providing access to much needed therapies for many.
Fantastic news for new #celltherapies being developed for #Myeloma #mmsm patients. This will allow for accelerated approval using MRD as an early endpoint providing access to much needed therapies for many.
Elizabeth Buchbinder, MD and Lauren Desnoyers, RN meet with a patient on Yawkey 5. Dr. Buchbinder and the #CellTherapies team are preparing to offer tumor-infiltrating lymphocyte (TIL therapy), recently approved for relapsed/refractory #melanoma. #DanaFarber
So excited to see this again for @AABB #AABB24 #Annual #meeting at #Houston #biotherapies #celltherapies #genetherapies #AsaTweets
So excited to see this again for @AABB #AABB24 #Annual #meeting at #Houston #biotherapies #celltherapies #genetherapies #AsaTweets
.@US_FDA approves #CART #celltherapies #Abecma + #Carvykti for earlier #myeloma use. bit.ly/49spw7Y
At the #AACR24 #CellTherapies in solid tumors session? Check out our 2 recent trials on #CARTcells in patients with #glioblastoma! Work led by Christine Brown @cityofhope: nature.com/articles/s4159… Work led by @StephenBagleyMD @DrORourke2 @PennMedicine: nature.com/articles/s4159…